Business
Currency:JPY
2024/FY
Stock NameRevenueRatio
Pharmaceutical research and development3.11B100.00%
Region
Currency:JPY
2024/FY
Stock NameRevenueRatio
Asia1.26B40.40%
United States1.13B36.32%
Japan710.93M22.88%
Others12.26M0.39%